在MAPK8IP3中,一种有毒的功能增益变体提供了对JIP3细胞作用的洞察力
Wei Zhang1, Swapnil Mittal1, Ria Thomas1
1n-Lorem Foundation, Carlsbad, California, USA.
JCI insight
|March 20, 2025
概括
一种MAPK8IP3基因突变导致有毒的功能增长,破坏轴突运输,导致神经发育障碍. 反感性寡核酸有效降低细胞中的突变JIP3水平,提供了一个潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- MAPK8IP3基因编码JIP3,这是通过kinesin-1复合体对轴突运输至关重要的蛋白质.
- MAPK8IP3中的突变与严重的神经发育障碍有关,包括智力障碍和自闭症.
研究的目的:
- 为了研究与神经发育缺陷相关的特定MAPK8IP3误解突变 (R578C) 的功能后果.
- 探索反感性寡核酸作为治疗MAPK8IP3相关疾病的治疗干预的潜力.
主要方法:
- 描述R578C突变对JIP3蛋白功能和细胞通路的影响.
- 评估轴突运输,特别是晚期内分泌体.
- 对c-Jun N-终端激酶和多巴胺受体信号通路的分析.
- 在体外评估酸改性反感寡核化物用于JIP3减少.
主要成果:
- R578C突变导致有毒的功能获取,改变JIP3的相互作用体并破坏轴突运输.
- 突变增加了c-Jun N-终端激酶信号传递,促进了细胞灭绝,并影响了多巴胺受体1信号传递.
- 非异位素选择性反感小核酸在体外显著降低了突变型和野生型JIP3水平,具有良好的细胞耐受性.
结论:
- 这项研究揭示了JIP3在细胞过程和疾病发病过程中的新角色.
- 用反感性寡核酸向JIP3减少,为由MAPK8IP3突变引起的神经发育障碍提供了一个有希望的治疗途径.
相关概念视频
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
IP3/DAG Signaling Pathway
11.8K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.8K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


